{"id":"W3005705527","doi":"10.1158/1538-7445.sabcs19-ot1-08-04","title":"Abstract OT1-08-04: A first-in-human phase Ia dose escalation study of GDC-0077, a p110a-selective and mutant-degrading PI3K inhibitor, in patients with <i>PIK3CA</i>-mutant solid tumors","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Palbociclib; Breast cancer; Cancer; Pharmacodynamics; Metastatic breast cancer; Phases of clinical research; Internal medicine; Adverse effect; Pharmacokinetics; Pharmacology; Oncology; Toxicity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001204822,0.001878559,0.001697188,0.0005626563,0.000527625,0.001402978,0.001233772,0.001314794,0.005017933],"category_scores_gemma":[0.0008514188,0.0006829616,0.001071206,0.0005988913,0.001306549,0.000941325,0.0004126535,0.00491888,0.001224728],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001763777,"about_ca_system_score_gemma":0.003329422,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002953374,"about_ca_topic_score_gemma":0.006021863,"domain_scores_codex":[0.999638,0.0001222631,0.00001745133,0.00005672422,0.00004415269,0.0001214894],"domain_scores_gemma":[0.9992944,0.00007445398,0.00009560308,0.00005603737,0.00005535884,0.000424012],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5465202,0.1557671,0.009413201,0.001364402,0.001540398,0.0005674053,0.0007345866,0.005181,0.09952606,0.0009388013,0.02124544,0.1572014],"study_design_scores_gemma":[0.5053715,0.4682941,0.01012699,0.00004685489,0.0004713314,0.0004327086,0.0001150856,0.001579573,0.00675173,0.0003607721,0.006401206,0.00004802461],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9849653,0.001197452,0.001096411,0.000628654,0.0001676141,0.004635296,0.003120965,0.0002764545,0.003911712],"genre_scores_gemma":[0.9778699,0.001570687,0.002861433,0.001442658,0.0001467244,0.003905345,0.005691285,0.0001014781,0.006410443],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005017933,"threshold_uncertainty_score":0.01678669,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0470059046040869,"score_gpt":0.3988687330718152,"score_spread":0.3518628284677283,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}